President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a new evaluation tool.

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is not well aligned with FDA’s authority to regulate drug safety and efficacy.

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or discriminatory” practices by foreign countries that result in Americans paying far higher costs for prescription drugs.

Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

Unlike Trump's first term, his proposed "most favored nation" policy, tying U.S. drug prices to the lowest prices paid by other developed countries, might make it this time.

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make sense of it

A new Medicare administrator, rising drug caps, and automatic enrollments are reshaping how you’ll handle healthcare next year.

WASHINGTON (AP) — President Donald Trump's plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he's even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs.